Voyager Therapeutics, Inc. (VYGR) Shareholders’ equity 2016–2025
Voyager Therapeutics, Inc. (VYGR) shareholders’ equity at each fiscal year-end, per SEC filings.
$196.1MFY2025 · since FY2016: $135.9M → $196.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $196.1M | -34.6% |
| FY2024 | $299.8M | +26.8% |
| FY2023 | $236.3M | +300.4% |
| FY2022 | $59.0M | -37.9% |
| FY2021 | $95.1M | -38.4% |
| FY2020 | $154.3M | +55.1% |
| FY2019 | $99.5M | +114.3% |
| FY2018 | $46.4M | -65.4% |
| FY2017 | $134.1M | -1.4% |
| FY2016 | $135.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice